The International Agency for Research on Cancer controversially has classified formaldehyde as causing nasopharyngeal carcinoma and myeloid leukemia. To provide further information on this question, we extended followup of a cohort of 14,008 chemical workers at 6 factories in England and Wales, covering the period 1941-2012. Mortality was compared with national death rates for England and Wales, and associations with incident upper airway cancer and leukemia were explored in nested case-control analyses. We observed excess deaths from cancers of the esophagus (100 observed vs. 93.1 expected), stomach (182 vs. 141.4), rectum (107 vs. 86.8), liver (35 vs. 26.9), and lung (813 vs. 645.8), but none of these tumors exhibited a clear exposure-response relationship. Nested case-control analyses of 115 men with upper airway cancer (including 1 nasopharyngeal cancer), 92 men with leukemia, and 45 men with myeloid leukemia indicated no elevations of risk in the highest exposure category (high exposure for ≥1 year). When the 2 highest exposure categories were combined, the odds ratio for myeloid leukemia was 1.26 (95% confidence interval: 0.39, 4.08). Our results provide no support for an increased hazard of myeloid leukemia, nasopharyngeal carcinoma, or other upper airway tumors from formaldehyde exposure. These results indicate that any excess risk of these cancers, even from relatively high exposures, is at most small.
Formaldehyde is a major industrial chemical, with total annual production in the United States and Western Europe exceeding 10 million tons (1) . Resins derived from formaldehyde are used to make adhesives and binders (e.g., for the manufacture of particle board, paper, and vitreous synthetic fibers), to make plastics and coatings, and in textile finishing (2) . In addition, formaldehyde is an intermediate in the production of various other chemicals, and in aqueous solution (formalin) it is used as a disinfectant and preservative. As well as the exposures that arise from its manufacture and use, it is encountered as a product of combustion (e.g., in vehicle exhausts and tobacco smoke) (2) . Moreover, it is formed endogenously in humans-for example, from metabolism of the methanol that occurs naturally in fruit (3).
In 2006, the International Agency for Research on Cancer (IARC) classified formaldehyde as a human carcinogen (1) . This decision was based on evidence that it was cytotoxic, was genotoxic, caused nasal cancer in rats when inhaled at high concentrations, and was associated with an increased risk of nasopharyngeal cancer in epidemiologic studies. The association with nasopharyngeal cancer was not entirely consistent, but it was apparent in a cohort study conducted by the US National Cancer Institute (NCI) of factories that made formaldehyde or products containing formaldehyde (4) ; in analyses of proportional mortality among US embalmers (5) and employees at Danish companies manufacturing or using formaldehyde (6) ; and in a number of case-control studies (7) (8) (9) (10) (11) ).
An increased hazard of nasopharyngeal cancer is plausible insofar as the nasopharynx is a site of direct contact with inhaled formaldehyde. More controversial is the possibility that formaldehyde might also cause leukemia. Suspicion of such an effect was raised by an elevated risk of myeloid leukemia associated with high peak exposures in the NCI cohort study (12) , an observation that was supported by increased risks in a cohort of garment manufacturers (13) and in earlier studies of embalmers, pathologists, and anatomists (5, (14) (15) (16) (17) (18) . On the other hand, a large study of workers heavily exposed to formaldehyde in the British chemical industry had found no excess risk of leukemia, although it did not examine risks for myeloid leukemia specifically (19) .
In 2006, the IARC did not consider the evidence sufficient to be confident that formaldehyde causes leukemia in humans (1) , but that position was revised in 2012, by which time the NCI study had been extended (20) and an association had also been observed in a nested case-control study of workers in the funeral industry (21) . Although most of the IARC monograph panel judged that the evidence for a hazard of leukemia was now sufficient, it remains uncertain how inhaled formaldehyde might reach hematopoietic stem cells at sufficient concentrations to induce malignancy, and other investigators have argued that the evidence is unconvincing (22, 23) .
Whether or not formaldehyde causes leukemia is an important question, because if it acts systemically and not only at anatomical sites which are directly exposed, there are implications for the risk assessment of other chemicals for which it is a product of metabolism. For example, the carcinogenicity of formaldehyde was recently raised as a concern in a risk assessment of the artificial sweetener aspartame, since aspartame is metabolized to formaldehyde via methanol (24) .
To provide further information on the risks of cancer from formaldehyde, we updated follow-up of the British cohort of chemical workers (19) by 12 years, with special focus on upper airway cancer and leukemia.
METHODS
The cohort was originally established in the early 1980s (19, 25, 26) and comprised men who had been employed at 6 chemical factories in England and Wales at a time when formaldehyde was produced or used, and for which employment records were thought to be complete (Table 1) . At 5 factories, all male employees were enrolled, while at the sixth (British Petroleum), where only a small proportion of the workforce had been exposed to formaldehyde, recruitment was limited to formaldehyde workers and a subset of men who had worked in other parts of the plant (2 for each exposed man).
Subjects were identified from personnel records, and information was abstracted on name, date of birth, and job history while employed at the factory. An occupational hygienist then classified job titles according to their exposure to formaldehyde (background, low, moderate, high, or unknown). Measurements of formaldehyde were not available from before 1970, but from later measurements and workers' recall of irritant symptoms, it was estimated that background exposure corresponded to time-weighted concentrations of <0.1 parts per million ( ppm), low exposure to 0.1-0.5 ppm, moderate exposure to 0.6-2.0 ppm, and high exposure to >2.0 ppm. Within each factory, each job title was assigned to the same exposure category across all time periods, but the same job title was not necessarily classified in the same exposure category at different factories.
Other substances handled at some of the factories included styrene, ethylene oxide, epichlorohydrin, asbestos, chromium salts, cadmium, and various organic solvents, but a At each time point during follow-up, subjects were classified according to the highest grade of exposure experienced up to that date. It was estimated that background exposure corresponded to time-weighted concentrations of <0.1 parts per million (ppm), low exposure to 0.1-0.5 ppm, moderate exposure to 0.6-2.0 ppm, and high exposure to >2.0 ppm.
b ICD-9 codes 140-208; ICD-10 codes C00-C97. c ICD-9 codes 390-459; ICD-10 codes I00-I99. d ICD-9 codes 460-519; ICD-10 codes J00-J99. e ICD-9 codes 008-009 and 520-579; ICD-10 codes K00-K93. f ICD-9 codes 800-999; ICD-10 codes U509 and V01-Y89.
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Statistical analysis
Statistical analysis was carried out with Stata software, version 13 (StataCorp LP, College Station, Texas).
We used the person-years method to compare the mortality of cohort members with that of the national population of England and Wales, according to category of exposure. These analyses were based on the underlying cause of death, and reference rates were for 5-year age bands and calendar periods (except for deaths occurring during 2010-2012, for which rates from the period 2005-2012 were used). Each man was considered to have been at risk from the latest of the following dates: 1) January 1, 1941; 2) the date from which employment records at the factory were believed to be complete; or 3) the date on which he entered the relevant exposure category. He then remained at risk until the earliest of the following dates: 1) exit from the relevant exposure category; 2) death; 3) loss to follow-up for other reasons (e.g., Risks for upper airway cancer (tumors of the lip, tongue, mouth, nose and nasal sinuses, pharynx, and larynx) and leukemia were then explored further in nested case-control analyses. For each outcome, we identified all men for whom the diagnosis was recorded as an underlying or contributing cause of death, or as a cancer registration. The date of diagnosis was taken as the first date on which the diagnosis was known to have been made. Each case was individually matched with up to 10 controls who 1) did not have the relevant diagnosis during the study period, 2) worked at the same factory as the case, 3) were alive and under follow-up when the case was diagnosed, and 4) had been born within 2 years of the case. This was achieved through an algorithm designed to ensure that the same control was not assigned to more than 1 case in the same diagnostic category (upper airway cancer or leukemia) and to minimize the number of cases with only a small number of controls. Where more than 10 possible controls were available for the same Abbreviations: CI, confidence interval; SMR, standardized mortality ratio. a At each time point during follow-up, subjects were classified according to the highest grade of exposure experienced up to that date. It was estimated that background exposure corresponded to time-weighted concentrations of <0.1 parts per million (ppm), low exposure to 0.1-0.5 ppm, moderate exposure to 0.6-2.0 ppm, and high exposure to >2.0 ppm.
b Because of changes in disease classification, the earliest follow-up for these cancers was from 1950 onward. c Because of changes in disease classification, the earliest follow-up for these cancers was from 1958 onward. case, we gave preference to those with closer dates of birth. Associations with level and duration of exposure to formaldehyde (at a time point defined for each matched set as 5 years before the date on which the case was first known to have been diagnosed) were assessed by conditional logistic regression and summarized by odds ratios.
Ethical approval
Ethical approval was originally provided by the British Medical Association Ethics Committee and was later reaffirmed by the National Research Ethics Service (South Central-Portsmouth Committee).
RESULTS
The number of men included in the analysis (n = 14,008) differed slightly from that in the last reported follow-up of the cohort (n = 14,014) (19) . Seventeen subjects from the previous analysis were excluded because they were found to be female (15) or had incorrect dates in their employment histories that had to be reclassified as unknown (2) . This loss was partially offset by inclusion of 11 men who had been omitted from the earlier analysis-1 previously thought to be female and 10 for whom dates in the employment history had been treated as missing but which could reasonably be imputed.
A total of 9,172 cohort members had exposures above the background level, including 3,991 who at some time were highly exposed. Most of the latter (86%) were employed at the British Industrial Plastics factory (Table 1) .
Within the total cohort of 14,008 men, 7,378 were known to have died by the end of the follow-up period (with 2,188 of the deaths occurring since the last published analysis of mortality (19)); 5,449 were still alive; and the other 1,181 had been lost to follow-up at an earlier stage. The last group included 171 men who could not be traced through the Health and Social Care Information Centre or social security records beyond their last known date of employment, and were followed only to that date.
Overall mortality in the cohort was significantly higher than expected from national rates (standardized mortality ratio (SMR) = 1.05, 95% confidence interval: 1.03, 1.08), as was that from all cancers (SMR = 1.10), respiratory disease (SMR = 1.13), and digestive disease (SMR = 1.22) ( Table 2 ). In addition, there was a nonsignificant excess of deaths from injury and poisoning (SMR = 1.10), whereas mortality from circulatory diseases was close to expectation (SMR = 0.99). The elevation in total mortality was attributable to high death rates at 3 factories (British Industrial Plastics and the Synthite facilities at Mold and West Bromwich), while at Ciba-Geigy, overall mortality was significantly lower than expected (SMR = 0.81). When the analysis was broken down by highest lifetime level of exposure, risk of death increased with exposure for all causes, all cancers, circulatory disease, respiratory disease, and digestive diseases, but not for injury and poisoning ( Table 2) .
The main contribution to the elevated mortality from cancer came from tumors of the esophagus (100 deaths observed vs. 93.1 expected), stomach (182 vs. 141.4), rectum (107 vs. 86.8), liver (35 vs. 26.9), and lung (813 vs. 645.8), and for each of these tumors, SMRs were even higher among men who had experienced high exposure (SMRs = 1.33-1.59) ( Table 3 and Web Table 2 ). When findings were broken down by factory, there was no excess of deaths from any of these tumors at Ciba-Geigy, but increased rates of lung cancer were observed at each of the other 5 factories, increased rates of cancers of the stomach, rectum, and liver at 4 factories, and increased rates of esophageal cancer at 3 factories (data not shown). Among men with high exposure, mortality was also increased for most categories of upper airway cancer (lip: 2 deaths observed vs. 0.2 expected; tongue: 3 vs. 2.1; mouth: 3 vs. 1.9; pharynx: 6 vs. 4.1; nose and nasal sinuses: 0 vs. 0.9; larynx: 11 vs. 5.6; total: 25 vs. 14.8). However, there was no excess mortality from nasopharyngeal cancer specifically; the only death occurred in a man with low/moderate exposure (1.7 deaths expected for exposures above background). For myeloid leukemia, there were 36 deaths overall as compared with 29.9 expected, but there was no elevation of mortality among men with high exposure (SMR = 0.93). Table 4 breaks down mortality by duration of high exposure for those cancers with more than 25 deaths in the high exposure category. None of the 7 types of tumors exhibited a clear exposure-response relationship. In particular, mortality from cancers of the esophagus, pancreas, and lung was highest in men who had incurred high exposure for less than 1 year. Table 5 shows risk ratios for death from lung cancer and respiratory disease by highest level of exposure, as estimated by Poisson regression with adjustment for factory. For both causes of death, risk was lower in men with prolonged high exposure than in those who had been highly exposed for less than 1 year. Furthermore, this pattern persisted when each man's first 35 years of follow-up were disregarded.
The nested case-control analyses focused on 115 men with upper airway cancer and 92 men with leukemia, including 45 with myeloid leukemia. Most were first identified from cancer registrations, including a substantial proportion who subsequently died with the cancer designated an underlying or (more rarely) contributing cause (Web Table 3 ). For 6 men with upper airway cancers, the site of cancer recorded on the death certificate differed from that which had been registered. The most common sites of upper airway cancer were the larynx (53 cases), pharynx (28 cases, including 1 cancer of the nasopharynx), mouth (14 cases), and tongue (9 cases).
We were able to find a total of 1,138 controls for the 115 men with upper airway cancer and 914 controls for the 92 men with leukemia, including 450 controls for the 45 men with myeloid leukemia. Four cases had fewer than 10 controls (2, 5, 6, and 9). Table 6 summarizes the relationship of upper airway cancer and leukemia to the highest category of exposure that had been experienced by the 5 years before case diagnosis. No significant associations were observed, and odds ratios for the highest category of exposure (high exposure for ≥1 year) were less than or close to 1 for cancer of the larynx, cancer of the mouth, cancer of the pharynx, cancer of the tongue, all upper airway cancer, myeloid leukemia, and all leukemia. When the 2 highest exposure categories were combined (i.e., all high exposure), the odds ratio for myeloid leukemia was 1.26 (95% confidence interval: 0.39, 4.08). Repeat analysis using a lag time of 2 years rather than 5 years gave similar results. 
DISCUSSION
Our study provides no evidence that formaldehyde poses an increased hazard either of upper airway cancer or of myeloid leukemia. Total mortality in the cohort was elevated, as was that from various more specific causes, but the pattern of results suggests that this was attributable to nonoccupational confounding factors and not an adverse effect of formaldehyde exposure.
Our analysis adds substantially to the last published results from the same cohort (19) , with inclusion of more than 2,000 additional deaths. Furthermore, through nested case-control studies, we were able to use data on cases ascertained from cancer registrations as well as death certificates. This not only enhanced statistical power but also gave greater assurance of diagnostic accuracy. We did not attempt independent histological review of cases, but it seems unlikely that diagnostic errors would have caused us to seriously underestimate Abbreviations: CI, confidence interval; SMR, standardized mortality ratio. a A high level of exposure to formaldehyde was estimated as greater than 2 ppm. Duration of high exposure was unknown for 43 men with high exposure. Abbreviations: CI, confidence interval; RR, risk ratio. a At each time point during follow-up, subjects were classified according to the highest grade of exposure experienced up to that date. It was estimated that background exposure corresponded to time-weighted concentrations of <0.1 parts per million (ppm), low exposure to 0.1-0.5 ppm, moderate exposure to 0.6-2.0 ppm, and high exposure to >2.0 ppm. risks. We did not carry out a person-years analysis based on cancer registrations because historically the completeness of cancer registration in England and Wales varied by region, and therefore national registration rates would not have provided a reliable reference.
Only limited data were available on levels of formaldehyde in the workplaces studied, precluding the derivation of quantitative metrics of cumulative and peak exposure. However, we are confident that our high exposure category corresponded to average concentrations of the order of 2 ppm or higher, and the absence of increased cancer risks among men with prolonged exposure at this level is reassuring.
We did not attempt to update job histories beyond the early 1980s, when the cohort was first assembled. However, by that time, relatively few cohort members (<5%) were still employed at the participating factories, and exposures were lower than in earlier years.
The elevation of total mortality in the cohort resulted largely from high death rates at 3 of the 6 participating factories (British Industrial Plastics and the Synthite plants at Mold and West Bromwich) and was most marked in men with high exposure. Causes of death that contributed importantly to the excess included cancers of the esophagus, stomach, rectum, liver, and lung, as well as respiratory disease and digestive disease. In addition, mortality from circulatory disease was increased among men with high exposure. It seems likely, however, that these findings are explained by nonoccupational factors. Most of the diseases contributing to the high overall mortality are associated with socioeconomic deprivation and also occurred at high rates in the general population of the areas surrounding the Synthite and West Bromwich factories (19) . In contrast, at Ciba-Geigy, which was located in a more prosperous and less industrialized area, total mortality was significantly lower than expected. Furthermore, analyses for cancers of the esophagus, stomach, rectum, and lung showed no clear exposure-response relationship for duration of high exposure to formaldehyde (Table 4 ). In addition, Poisson regression indicated that mortality from lung cancer and respiratory disease was highest in men who had experienced high exposure for less than 1 year and was close to expectation in men with high exposure for ≥15 years (Table 5 ). The fact that this pattern persisted when the first 35 years of each man's follow-up were disregarded suggests that the finding was not attributable to healthy worker selection bias.
Two other large cohort studies have examined patterns of mortality among formaldehyde workers in the manufacturing industry. In the most recent follow-up of the NCI cohort, there was a slightly increased risk of death from all causes among exposed workers (SMR = 1.03), but mortality was lower in the highest category of cumulative exposure (27) . Similarly, although there was an overall excess of lung cancer (SMR = 1.20), risk declined significantly with increasing cumulative exposure, while deaths from circulatory and respiratory disease were close to expectation and there was a nonsignificant deficit of deaths from liver cancer. In the other study, which followed up more than 11,000 garment manufacturers in the US states of Georgia and Pennsylvania, Abbreviations: CI, confidence interval; OR, odds ratio. a At each time point during follow-up, subjects were classified according to the highest grade of exposure experienced up to that date. It was estimated that background exposure corresponded to time-weighted concentrations of <0.1 parts per million (ppm), low exposure to 0.1-0.5 ppm, moderate exposure to 0.6-2.0 ppm, and high exposure to >2.0 ppm.
b All risk estimates were calculated relative to the background exposure level and relate to exposure status 5 years before the case (for controls, the matched case) was first known to have been diagnosed.
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When the results from our study are set alongside these findings, there is little to suggest that formaldehyde increases the risk of any of the most common causes of death. Nasopharyngeal cancer is rare in Western populations, and only 1 death from this disease was recorded in our cohort as compared with 1.7 expected in men with more than background exposure. However, there was a suggestion of increased mortality from other upper airway cancers among men with high exposures to formaldehyde. We therefore undertook a nested case-control study of upper airway cancers (the lip, tongue, mouth, pharynx, and larynx, but not salivary glands), which, along with the nasopharynx, have the greatest potential for direct contact with inhaled formaldehyde.
A further justification for considering these cancers as a group was that within the upper airway, distinguishing the exact site of origin of a tumor is not always straightforward. This may explain why some cases had different upper airway cancers recorded on death certificates from those which had been registered during life. By combining all upper airway cancers and by ascertaining cases from cancer registrations as well as death certificates, we were able to base our analysis on 115 cases-substantially more than the 56 deaths from these tumors in the person-years analysis of mortality. However, no relationship was found with level of exposure to formaldehyde, either for upper airway cancers collectively or for cancers at specific sites in the upper airway (Table 6 ).
In person-years analyses, mortality from myeloid leukemia was a little higher than expected (36 deaths observed vs. 29.9 expected), but there was no increased risk among men with high exposure (SMR = 0.93); nor did the nested case-control analysis, which included an additional 9 cases, give any indication of a hazard, and there was no association with leukemia more broadly.
Although risk of myeloid leukemia was higher among members of the NCI cohort with higher peak exposures to formaldehyde, there was no overall excess of the disease in exposed workers, and no relationship to cumulative exposure (20) . Similarly, a case-control study of deaths among a population of embalmers found higher risk of myeloid leukemia with increasing duration of embalming (21) but no increase in proportional mortality for the cohort as a whole. Additionally, in the other major cohort study of an industrial population exposed to formaldehyde, risk of myeloid leukemia was increased in people employed as garment workers for 10 years or longer (SMR = 1.84), but not to the point of statistical significance (28) . In the context of this relatively weak epidemiologic evidence, our results call into question the IARC's classification of formaldehyde as a cause of myeloid leukemia.
In summary, while our results do not exclude the possibility that formaldehyde causes myeloid leukemia, nasopharyngeal carcinoma, or other upper airway tumors, they provide no support for excess risks of these cancers. Furthermore, they indicate that if such hazards do exist, then the absolute risks, even from relatively high exposures, are at most small.
